99%+ HPLC Pure | Batch-Specific Third-Party COAs | Free Shipping $250+ | Same-Day Shipping Before 2PM CT | Ships Across the US
Tirzepatide 40mg
$174.00
NEW
99.3% HPLC-Verified Dual GLP-1/GIP Agonist · Third-Party Tested · COA Included
In stock
Product Details
Tirzepatide 40mg is a high-purity, research-grade dual GIP and GLP-1 receptor agonist peptide supplied for laboratory investigation of incretin signaling and metabolic regulation. Every batch is HPLC-tested and ships with a batch-specific third-party Certificate of Analysis (COA) confirming identity and 99%+ purity. For laboratory and research use only. Not for human consumption. This product is not a drug, supplement, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease.
Research Applications
Tirzepatide is one of the most widely studied dual-incretin peptides in current metabolic research. Investigators use it in in-vitro and preclinical models to explore glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor co-activation, insulin-signaling pathways, appetite and energy-balance circuits, and body-composition endpoints. Its dual-agonist mechanism makes it a common reference compound in comparative studies of next-generation metabolic peptides.
Certificate of Analysis (COA) — Batch TIR-26070101
This product ships with an independent, batch-specific Certificate of Analysis from Renew Labs. The full COA document is posted in the product photo gallery above so researchers can verify identity and purity before use. Verified specifications for Batch No. TIR-26070101 (Mfg Jul 1, 2026 / Retest Jul 1, 2028):
- Product / CAS No.: Tirzepatide Acetate — CAS 2023788-19-2
- Molecular formula / weight: C225H348N48O68 — 4813.45 g/mol
- Appearance: White powder (Spec: white to off-white powder) — Pass
- HPLC purity: 99.4% (Spec: NLT 98.0%) — Pass
- Mass spectrum (ESI): 4813.3 (Spec: 4813.5 ± 2.0) — Pass
- Peptide content: 91.2% (Spec: NLT 80.0%) — Pass
- Water content (Karl Fischer): 3.8% (Spec: NMT 8.0%) — Pass
- Bacterial endotoxins: Conforms (Spec: NMT 10 EU/mg) — Pass
- Residual solvents: Conforms to ICH Q3C — Pass
Recommended storage: short term 2–8°C; long term below -10°C, protected from light and moisture. This batch complies with the Enterprise Standard and is supplied strictly as a chemical product for research and development use only.
Purity & Verification
Every lot is analyzed by reversed-phase HPLC and, where applicable, mass spectrometry to confirm compound identity and 99%+ purity. A batch-specific, third-party Certificate of Analysis (COA) is included in the product gallery so researchers can confirm purity and identity before use. Supplied as a lyophilized (freeze-dried) powder; store sealed, cool, dry, and protected from light, and reconstitute per standard laboratory handling. Fast, tracked shipping from within the United States.
Peptide Research & Literature
Tirzepatide is one of the most extensively studied dual-incretin agonists in published clinical literature. Selected published literature includes:
- Rosenstock J, et al. "Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial." The Lancet, 2021. PMID: 34186022
- Garvey WT, et al. "Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial." The Lancet, 2023. PMID: 37385275
These citations are provided for research reference only and do not imply any claim about the effects of this product.
Frequently Asked Questions
What is Tirzepatide used for in research?
Tirzepatide is studied in preclinical and in-vitro models of incretin signaling, glucose metabolism, and energy balance. It is supplied strictly for laboratory research and not for human or animal use.
How pure is Kynetide Tirzepatide?
Each batch is HPLC-verified to 99%+ purity and ships with a batch-specific third-party COA documenting identity and purity. The current batch (TIR-26070101) tested at 99.4% purity.
Is a COA included?
Yes. A batch-specific third-party Certificate of Analysis is provided in the product gallery for every lot, including HPLC purity, mass spectrometry, peptide content, water content, and endotoxin results.
What is the CAS number and molecular formula of Tirzepatide?
Tirzepatide Acetate is CAS 2023788-19-2, with molecular formula C225H348N48O68 and a molecular weight of approximately 4813.45 g/mol, as confirmed by mass spectrometry on the batch-specific COA.
How should Tirzepatide be stored?
As a lyophilized powder it is best kept sealed, cool, dry, and away from light per standard laboratory handling; short term 2-8°C or long term below -10°C.
What documentation comes with each order?
Each order includes a batch-specific third-party Certificate of Analysis documenting HPLC purity, mass spectrometry, peptide content, and contaminant testing.
Is this the same compound referenced in the published research literature?
Yes. Tirzepatide (CAS 2023788-19-2) is the same dual GIP/GLP-1 receptor agonist studied in the peer-reviewed clinical trial literature cited above.
For laboratory and research use only. Not for human consumption. This product is not a drug, supplement, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease.
Tirzepatide 40mg
